CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name

Chapter 2 - Neoplasms (C00-D49)»Neoplasms of unspecified behavior (D49)»Neoplasms of unspecified behavior (D49)

D49

Neoplasms of unspecified behavior

Sub-codes (10)

  • D49.0 Neoplasm of unspecified behavior of digestive system
  • D49.1 Neoplasm of unspecified behavior of respiratory system
  • D49.2 Neoplasm of unspecified behavior of bone, soft tissue, and skin
  • D49.3 Neoplasm of unspecified behavior of breast
  • D49.4 Neoplasm of unspecified behavior of bladder
  • D49.5 Neoplasm of unspecified behavior of other genitourinary organs
  • D49.6 Neoplasm of unspecified behavior of brain
  • D49.7 Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system
  • D49.8 Neoplasm of unspecified behavior of other specified sites
  • D49.9 Neoplasm of unspecified behavior of unspecified site

Related indications (MeSH) (1)

Neoplasms4932 drugs (787 approved, 4145 experimental)

New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.